Dual antibody-aided mesoporous nanoreactor for H(2)O(2) self-supplying chemodynamic therapy and checkpoint blockade immunotherapy in triple-negative breast cancer

Triple-negative breast cancer (TNBC) represents a formidable challenge due to the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) expression, rendering it unresponsive to conventional hormonal and targeted therapies. This study intro...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Ying-Tzu, Luo, Ying-Xiang, Chan, Shih-Hsuan, Chiu, Wen-Yi, Yang, Hung-Wei W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594761/
https://www.ncbi.nlm.nih.gov/pubmed/37875918
http://dx.doi.org/10.1186/s12951-023-02154-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594761/
https://www.ncbi.nlm.nih.gov/pubmed/37875918
http://dx.doi.org/10.1186/s12951-023-02154-0

Ejemplares similares